LCN2 and hemochromatosis type 1: Chronic excretion of urine NGAL > 5 ng/ml also showed a significant association with combined deferoxamine and deferiprone treatment (OR 3.69, p = 0.011), female gender (OR 5.15, p < 0.001), hemochromatosis (OR 3.01, p = 0.012), elevated serum LDH (OR 2.81, p = 0.018) and chronic proteinuria (OR 2.63, p = 0.025).